Skip to main content

Shionogi & Co. Value Stock - Dividend - Research Selection

Shionogi & Co., Ltd.

ISIN: JP3347200002, WKN: 855648

Market price date: 19.07.2021
Market price: 5.694,00 JPY




Shionogi & Co., Ltd. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 18-05-2021
Cash flow
Net operating cash flow 109.039.000.000
Capital Expenditures -28.182.000.000
Free cash flow 80.856.997.888
Balance sheet
Total Equity 864.550.000.000
Liabilities & Shareholders equity 998.992.000.000
Income statement
Net income 111.858.000.000
Eps (diluted) 364,890
Diluted shares outstanding 306.550.000
Net sales/revenue 297.177.000.000

Fundamental ratios calculated on: 19-07-2021

Ratios
Key figures 19-07-2021
Cash flow
P/C 16,01
   
P/FC 21,59
Balance sheet
ROI11,20
ROE86,54
Income statement
P/E15,61
Div. Yield1,90%
P/B2,02
P/S5,87


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol4507.TSE
Market Capitalization16.828.596.224,00 USD
Country
IndicesNIKKEI 225
Sectors
Raw Data SourceIFRS in Millionen JPY
Stock Split
Internetwww.shionogi.co.jp


Description of the company

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company. It is engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The Company mainly provides vitamin preparations, analgesic antipyretics, cold and sinus medicine, digestive medicine, dermatologic preparations, antiphlogistic analgetics, antihypercholesterolemic agents, test paper for glucose in urine and artificial teeth-related products. As of March 31, 2014, the Company had 37 subsidiaries and six associated companies.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.shionogi.co.jp